A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs
- PMID: 36612865
- PMCID: PMC9819103
- DOI: 10.3390/ijerph20010543
A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs
Abstract
Compared with other racial/ethnic groups in the United States, American Indians/Alaska Natives have the highest rates of acute Hepatitis C Virus (HCV) infection, the highest HCV-related mortality, and one of the fastest climbing rates of drug overdose deaths involving stimulants. In this pilot study, a life history calendar was administered to Indigenous people who use injection drugs (IPWIDs) to understand sequences of polysubstance use across the lifespan. 40 IPWIDs completed a questionnaire and life history calendar. Social sequence analysis was used to examine patterns in sequential phenomena among substances reported over years of the lifespan. Most participants (55%) began injecting substances before the age of 21, 62.5% shared syringes with others, and 45% had ever been diagnosed with HCV. An appreciably large increase in the use of stimulants occurred between the year prior to and following injection initiation (33% to 82%). A three-cluster solution distinguished younger IPWIDs transitioning into polysubstance use involving stimulants and/or narcotic analgesics from adults using narcotic analgesics with stimulants over longer periods of time, and adults most focused on stimulant use over time. Findings from this pilot study contribute to an understanding of how methamphetamine injection plays a role in the HCV epidemic among IPWIDs.
Keywords: American Indians/Alaska Natives; hepatitis C; injection drugs; life history calendar; methamphetamine; polysubstance use; social sequence analysis.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- US Centers for Disease Control and Prevention Figure 3.6. Rates of Reported Acute Hepatitis C Virus Infection, by Race/Ethnicity—United States, 2004–2019. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Viral Hepatitis Surveillance, United States. [(accessed on 19 May 2022)];2019 Available online: https://www.cdc.gov/hepatitis/statistics/2019surveillance/Figure3.6.htm.
-
- US Centers for Disease Control and Prevention Table 3.8. Number and Rates of Deaths with Hepatitis C Virus Infection Listed as a Cause of Death Among Residents, by Demographic Characteristics—United States, 2015–2019. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Viral Hepatitis Surveillance, United States. [(accessed on 19 May 2022)];2019 Available online: https://www.cdc.gov/hepatitis/statistics/2019surveillance/Table3.8.htm.
-
- Roehler D., Hoots E., Olsen M., Kariisa N., Otoo Wilson R., Rudd D., Mustaquim L., Xu L., Schieber L. Annual Surveillance Report of Drug-Related Risks and Outcomes, United States. Centers for Disease Control and Prevention. [(accessed on 23 December 2022)];2019 Available online: https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-rep....
-
- Centers for Disease Control and Prevention Age-Adjusted Rates of Drug Overdose Deaths Involving Prescription Opioids, Heroin, Cocaine, and Psychostimulants with Abuse Potential, with (A) and without (B) Synthetic Opioids Other Than Methadone—United States, 2013–2019. National Vital Statistics System, Mortality File. [(accessed on 19 May 2022)];2020 Available online: https://www.cdc.gov/mmwr/volumes/70/wr/mm7006a4.htm?s_cid=mm7006a4_w#F1_....
-
- Evans M., Person M., Reilley B., Leston J., Haverkate R., McCollum J., Apostolou A., Bohm M., Van Handel M., Bixler D., et al. Trends in indicators of injection drug use, Indian Health Service, 2010–2014: A study of health care encounter data. Public Health Rep. 2020;135:461–471. doi: 10.1177/0033354920937284. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical